Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 13,478 | 13,135 | 14,249 | 11,371 | 10,411 |
| Operating Income | -13,478 | -13,135 | -14,249 | -11,371 | -10,411 |
| Other Income | 1,868 | 1,828 | 1,385 | 661 | 260 |
| Pre-tax Income | -11,610 | -11,307 | -12,864 | -10,710 | -10,151 |
| Net Income Continuous | -11,610 | -11,307 | -12,864 | -10,710 | -10,151 |
| Net Income | $-11,610 | $-11,307 | $-12,866 | $-10,710 | $-10,151 |
| EPS Basic Total Ops | -0.28 | -0.28 | -0.32 | -0.26 | -0.25 |
| EPS Basic Continuous Ops | -0.28 | -0.28 | -0.31 | -0.26 | -0.25 |
| EPS Diluted Total Ops | -0.28 | -0.28 | -0.32 | -0.26 | -0.25 |
| EPS Diluted Continuous Ops | -0.28 | -0.28 | -0.31 | -0.26 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.28 | -0.32 | -0.26 | N/A |
| EBITDA(a) | $-13,725 | $-13,417 | $-14,288 | $-11,136 | $-10,204 |